We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+1.19%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$17.7B
AUM Growth
+$1.44B
(+8.9%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
8.95%
Top 10 Holdings %
Top 10 Hldgs %
19.92%
Holding
1,403
New
439
Increased
358
Reduced
346
Closed
241
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$403M |
| 2 |
Walt Disney
DIS
|
+$157M |
| 3 |
CELG
Celgene Corp
CELG
|
+$141M |
| 4 |
Citigroup
C
|
+$137M |
| 5 |
Starbucks
SBUX
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$244M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$178M |
| 3 |
Canadian National Railway
CNI
|
+$146M |
| 4 |
AT&T
T
|
+$139M |
| 5 |
Micron Technology
MU
|
+$134M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 17.79% |
| 3 | Healthcare | 17.78% |
| 4 | Consumer Staples | 7.98% |
| 5 | Consumer Discretionary | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JUNO
576
DELISTED
Juno Therapeutics, Inc.
JUNO
| $2.64M | 0.01% |
+49,500
| New | +$2.63M |
|
577
Universal Health Services
UHS
$10.5B
| $2.64M | 0.01% |
18,574
-225,345
| -92% | -$28.2M |
|
578
John B. Sanfilippo & Son
JBSS
$972M
| $2.64M | 0.01% |
50,781
+20,406
| +67% | +$1.02M |
|
579
Lifecore Biomedical
LFCR
$190M
| $2.64M | 0.01% |
182,693
-3,738
| -2% | -$53.9K |
|
580
Edgewell Personal Care
EPC
$1.31B
| $2.6M | 0.01% |
19,800
+15,621
| +374% | +$1.61M |
|
|
ORIG
581
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
| $2.59M | 0.01% |
55
+53
| +2,650% | +$3.51M |
|
582
CorVel
CRVL
$3.19B
| $2.59M | 0.01% |
242,463
-14,127
| -6% | -$164K |
|
|
AFFX
583
DELISTED
Affymetrix Inc
AFFX
| $2.58M | 0.01% |
+236,480
| New | +$2.87M |
|
584
Polaris
PII
$4.07B
| $2.58M | 0.01% |
17,409
-7,506
| -30% | -$1.08M |
|
585
Halliburton
HAL
$26.6B
| $2.58M | 0.01% |
+59,800
| New | +$2.76M |
|
586
ResMed
RMD
$30.7B
| $2.58M | 0.01% |
+45,700
| New | +$2.88M |
|
|
SJR
587
DELISTED
Shaw Communications Inc.
SJR
| $2.56M | 0.01% |
117,700
-935,797
| -89% | -$21M |
|
|
WP
588
DELISTED
Worldpay, Inc.
WP
| $2.52M | 0.01% |
66,100
+53,900
| +442% | +$2.14M |
|
|
CAM
589
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $2.52M | 0.01% |
+48,200
| New | +$2.5M |
|
590
Manhattan Associates
MANH
$11.4B
| $2.52M | 0.01% |
42,305
+16,205
| +62% | +$897K |
|
|
BRLI
591
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $2.51M | 0.01% |
+60,771
| New | +$2.18M |
|
|
COHR
592
DELISTED
Coherent Inc
COHR
| $2.5M | 0.01% |
39,334
+3,500
| +10% | +$225K |
|
|
BEAV
593
DELISTED
B/E Aerospace Inc
BEAV
| $2.47M | 0.01% |
+45,000
| New | +$2.68M |
|
|
WW
594
DELISTED
WW International
WW
| $2.47M | 0.01% |
509,370
-117,490
| -19% | -$781K |
|
595
Trimble
TRMB
$13.9B
| $2.46M | 0.01% |
104,890
+88,700
| +548% | +$2.17M |
|
596
Cirrus Logic
CRUS
$6.26B
| $2.46M | 0.01% |
+72,300
| New | +$2.55M |
|
597
Citi Trends
CTRN
$605M
| $2.42M | 0.01% |
99,988
+16,247
| +19% | +$402K |
|
|
SNCR
598
DELISTED
Synchronoss Technologies
SNCR
| $2.4M | 0.01% |
+5,833
| New | +$2.51M |
|
599
Diageo
DEO
$53.6B
| $2.39M | 0.01% |
+20,600
| New | +$2.34M |
|
600
Baidu
BIDU
$37.2B
| $2.37M | 0.01% |
+11,900
| New | +$2.44M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2015 Portfolio in Review
As of Q2 2015, Arrowstreet Capital held 1,403 positions worth $17.7B, up 8.9% from $16.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Arrowstreet Capital deployed $1.58B of net new capital in Q2 2015, opening 439 new positions and adding to 358 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,922,584 shares worth $114M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Union Pacific, an estimated $244M trimmed.
- Arrowstreet Capital's largest Q2 2015 buy was Teva Pharmaceuticals: 1,922,584 shares worth $114M.
- Arrowstreet Capital added most to Apple in Q2 2015, an estimated $403M increase.
- Arrowstreet Capital's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $244M.
- Arrowstreet Capital fully exited Canadian National Railway in Q2 2015, selling an estimated $146M.
- Arrowstreet Capital's ten largest holdings make up 20% of its $17.7B portfolio in Q2 2015.
- Arrowstreet Capital opened 439 new positions and closed 241 in Q2 2015.
- Arrowstreet Capital's portfolio value rose 8.9% quarter-over-quarter to $17.7B.
Based on Arrowstreet Capital's 13F filing for Q2 2015, filed 13 Aug 2015.